Japan Tobacco Inc (2914) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Japan Tobacco Inc (JT Group) is a tobacco company that primarily manufactures cigarettes. It also manufactures, markets and sells varied pharmaceutical and processed food products such as frozen cooked rice and noodles, instant noodles, bread and frozen bread, mineral water, and seasoning, prescription drugs and generic drugs. The company supplies the products to supermarkets, convenience stores, street and train station kiosks, small independent retailers and vending machines. JT Group caters to retail, industrial and commercial customers in Japan, Europe, CIS, Africa, the Middle East, Asia and Americas and other regions. The company manufactures its products in its own facilities in Japan and other countries and markets them through print, billboards, electronic media, promotional events, and brand sponsorship. JT Group is headquartered in Tokyo, Japan.

Japan Tobacco Inc (2914) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Japan Tobacco Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Japan Tobacco, Torii Pharmac and Sumitomo Dainippon Pharma Enter into Partnership 10
Japan Tobacco Enters into Agreement with Torii Pharma 11
Japan Tobacco Enters Into Co-Marketing Agreement With Torii Pharma For JTK-303 12
Licensing Agreements 13
Torii Pharma Enters into Licensing Agreement with Japan Tobacco 13
Japan Tobacco Enters into Licensing Agreement with EirGen Pharma 14
Japan Tobacco Enter into Licensing Agreement with Torii Pharmaceutical 15
JW Pharma Enters into Licensing Agreement with Japan Tobacco 16
Japan Tobacco and Torii Pharma Enter into Licensing Agreement with Menlo Therapeutics 17
Leo Pharma Enters into Licensing Agreement with Japan Tobacco for JTE-052 18
Japan Tobacco, Torii Pharmac Enter into Licensing Agreement with ALK-Abello 19
Asset Transactions 20
Metrion Biosciences Acquires Rights to Small Molecule Potassium Channel Inhibitors from Japan Tobacco 20
Japan Tobacco Inc - Key Competitors 21
Japan Tobacco Inc - Key Employees 22
Japan Tobacco Inc - Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 26
Clinical Trials 26
Jan 12, 2018: Top-line Results of the Topical JTE-052 JAK Inhibitor Phase 3 Clinical Study (Comparative Study) in Japan 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List Of Tables

List of Tables
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Japan Tobacco Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Japan Tobacco Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Japan Tobacco, Torii Pharmac and Sumitomo Dainippon Pharma Enter into Partnership 10
Japan Tobacco Enters into Agreement with Torii Pharma 11
Japan Tobacco Enters Into Co-Marketing Agreement With Torii Pharma For JTK-303 12
Torii Pharma Enters into Licensing Agreement with Japan Tobacco 13
Japan Tobacco Enters into Licensing Agreement with EirGen Pharma 14
Japan Tobacco Enter into Licensing Agreement with Torii Pharmaceutical 15
JW Pharma Enters into Licensing Agreement with Japan Tobacco 16
Japan Tobacco and Torii Pharma Enter into Licensing Agreement with Menlo Therapeutics 17
Leo Pharma Enters into Licensing Agreement with Japan Tobacco for JTE-052 18
Japan Tobacco, Torii Pharmac Enter into Licensing Agreement with ALK-Abello 19
Metrion Biosciences Acquires Rights to Small Molecule Potassium Channel Inhibitors from Japan Tobacco 20
Japan Tobacco Inc, Key Competitors 21
Japan Tobacco Inc, Key Employees 22
Japan Tobacco Inc, Subsidiaries 24

List Of Figures

List of Figures
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Japan Agency for Medical Research and Development - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Japan Agency for Medical Research and Development (AMED) is a medical research and development administrative agency that specializes in the field of medicine. The agency establishes and maintains medical research

USD 250 View Report

Japan Petroleum Exploration Co Ltd (1662) - Oil and Gas - Deals and Alliances Profile

Japan Petroleum Exploration Co Ltd (JAPEX) is an oil and gas company that offers exploration, development, production, and sales of oil, natural gas, and other energy resources. The companys services

USD 250 View Report

JAPAN TOBACCO INC Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

JAPAN TOBACCO INC Company Profile is a detailed strategic and analytical report on JAPAN TOBACCO INC. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200 View Report

Japan Tobacco Inc in Tobacco (Japan)

Within tobacco, the emergent heated tobacco category is set to be the key area of focus for Japan Tobacco Inc, as it looks to develop its Ploom TECH brand.Euromonitor International

USD 150 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available